BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.

MLA

Mu, Jianfeng, et al. “BRD9 Inhibition Promotes PUMA-Dependent Apoptosis and Augments the Effect of Imatinib in Gastrointestinal Stromal Tumors.” Cell Death & Disease, vol. 12, no. 11, Oct. 2021, p. 962. EBSCOhost, https://doi.org/10.1038/s41419-021-04186-6.

APA

Mu, J., Sun, X., Zhao, Z., Sun, H., & Sun, P. (2021). BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors. Cell Death & Disease, 12(11), 962. https://doi.org/10.1038/s41419-021-04186-6

Chicago

Mu, Jianfeng, Xuezeng Sun, Zhipeng Zhao, Hao Sun, and Pengda Sun. 2021. “BRD9 Inhibition Promotes PUMA-Dependent Apoptosis and Augments the Effect of Imatinib in Gastrointestinal Stromal Tumors.” Cell Death & Disease 12 (11): 962. doi:10.1038/s41419-021-04186-6.